Lenar Aimee J. 4

What Happened

• Aimee J. Lenar, EVP, U.S. Pharmaceuticals at Bausch Health (BHC), was awarded 157,139 restricted share units (RSUs) on 2026-02-25 (no purchase price). On 2026-02-26, 17,578 common shares were withheld to satisfy tax withholding obligations at $6.04 per share (total ~$106,171). The award itself is an equity grant (not an open-market purchase).

Key Details

• Transaction dates and amounts:
  • 2026-02-25: Award/grant of 157,139 RSUs (code A), acquisition recorded at $0.00.
  • 2026-02-26: Tax withholding (code F) of 17,578 shares disposed at $6.04 each, amounting to $106,171.
• Vesting and settlement: Footnote F1 — the RSUs vest one-third on each of the first three anniversaries of the grant date, subject to continued service; vested RSUs are settled in common shares.
• Withholding: Footnote F2 — the 17,578 shares represent shares withheld to satisfy tax withholding upon vesting/settlement.
• Shares owned after the transaction: Not specified in the provided filing details.
• Filing timeliness: Report filed 2026-02-27 for transactions dated 2026-02-25–26; this appears to be filed within the standard two-business-day window.

Context

• This was an equity award (RSUs), not a cash purchase; RSUs are compensation and typically vest over time. The withholding of shares for taxes is a routine, administrative step (similar to a cashless withholding) and does not, by itself, indicate a buy or sell signal from the insider.